If a company's history and track record were good enough reasons to buy its shares, it'd be easy to make a case for investing ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...

Robert Ford’s comments come as new CGMs and insulin pumps continue to roll out in the diabetes tech space, including over-the-counter glucose sensors.

Normoglycemic individuals spent 87% of their daily time in in the “tight range” of glucose levels (70-140 mg/dL) and the remainder above 140 mg/dL.

Abbott's recent results show 7.6% organic revenue growth, driven by medical devices and pharmaceuticals. Click here to read ...

DexCom's key Q3 earnings factors include Stelo sales, updates on sales channels, and potential share buybacks. See why I ...

Abbott’s earnings for the third quarter (Q3) of 2024 saw global sales reach $10.6 billion, a strong performance driven by the ...

HD Hyundai Marine Solution signed a memorandum of understanding with France's CMA-CGM and Korea's HD Hyundai Samho to use ...

In recent years, digital health has become a new development trend in the global health and medical industry. By using ...

Container freight rates look to have bottomed out this year and the prospects for next year are uncertain, according to ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third quarter 2024 investor letter. A ...

Ramon Fernandez told Les Echos that a one-off tax on high-earning companies to fill a gap in France’s finances could cost CMA ...